1403458-33-2

Upstream product

• 1403458-59-2 tert-butyl 2-(6-(methoxycarbonyl)-2-morpholino-4-oxo-4H-chromen-8-yl)pyrrolidine-1-carboxylate 
• 1403459-00-6 tert-butyl (2R)-2-(6-(methoxycarbonyl)-2-morpholino-4-oxo-4H-chromen-8-yl)pyrrolidine-1-carboxylate 
• 1403458-71-8 methyl 8-[(2R)-(1-(3-fluorophenyl)pyrrolidin-2-yl)]-2-morpholino-4-oxo-4H-chromene-6-carboxylate 
• 1403458-64-9 methyl 2-morpholino-4-oxo-8-[(2R)-pyrrolidin-2-yl]chromene-6-carboxylate 
• 1403458-58-1 tert-butyl 2-(6-(methoxycarbonyl)-2-morpholino-4-oxo-4H-chromen-8-yl)-1H-pyrrole-1-carboxylate 
• 1296271-38-9 methyl 3-bromo-4-hydroxy-5-(3-morpholino-3-oxopropanoyl)benzoate 
• 62604-08-4 4-morpholinecarbodithioic acid methyl ester 
• 71407-98-2 3-acetyl-5-bromo-4-hydroxybenzoic acid 
• 1296271-33-4 methyl 8-bromo-2-morpholino-4-oxo-4H-chromene-6-carboxylate 
• 57009-12-8 methyl 3-acetyl-4-hydroxybenzoate 
• 160753-84-4 methyl 3-acetyl-5-bromo-4-hydroxybenzoate 
• 52631-31-9 4-(dichloromethylene)morpholin-4-ium chloride 
• 29415-97-2 methyl 3-bromo-4-hydroxybenzoate 
• 99-76-3 methyl 4-hydroxylbenzoate 

Relevant academic research and scientific papers

CHROMENONE DERIVATIVES

The invention concerns chromenone compounds of Formula I; or pharmaceutically-acceptable salts thereof, wherein each of R1, R2, R3, R4, R5, n and R6 has any of the meanings defined hereinbe

CHROMENONE COMPOUNDS AS PI 3 -KINASE INHIBITORS FOR THE TREATMENT OF CANCER

The invention concerns chromenone compounds of Formula I; or pharmaceutically-acceptable salts thereof, wherein each of R1, R2, R3, R4, R5, n and R6 has any of the meanings defined hereinbe